The client wanted to understand how radiation oncologists viewed an upcoming treatment for head and neck cancer. This included their perceptions of its efficacy and safety, potential barriers to prescribing, and likelihood of using the treatment once it became available.
Borderless Access engaged with 50 radiation oncologists across the USA, Germany, France, and Italy through in-depth research discussions. The study explored physicians’ perceptions of the upcoming treatment, the factors that could influence its future use, and their likelihood of prescribing it once available.
The findings helped the client assess the market potential for the upcoming treatment, identify gaps and opportunities, and support strategic planning and resource allocation around patient care and treatment outcomes.




© 2026 Borderless Access Pvt Ltd. All Rights Reserved.